Business Description
Shanghai Rongtai Health Technology Corp Ltd
ISIN : CNE100002R81
Share Class Description:
SHSE:603579: Class ACompare
Compare
Traded in other countries / regions
603579.China IPO Date
2017-01-11Description
Shanghai Rongtai Health Technology Corp Ltd is a China based company engaged in development, manufacturing and marketing of massage equipment. It also offers technology health solutions. The company's products include eye massager, massage chair series, mini massage chair, partial massage series products, massage stick, and waist massager.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.01 | |||||
| Equity-to-Asset | 0.57 | |||||
| Debt-to-Equity | 0.52 | |||||
| Debt-to-EBITDA | 4.52 | |||||
| Interest Coverage | 32.46 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 2.7 | |||||
| Beneish M-Score | -2.56 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3 | |||||
| 3-Year EBITDA Growth Rate | 7.7 | |||||
| 3-Year EPS without NRI Growth Rate | 6.6 | |||||
| 3-Year FCF Growth Rate | 43.6 | |||||
| 3-Year Book Growth Rate | 6.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 21.96 | |||||
| Future 3-5Y Total Revenue Growth Rate | 15.36 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 38.9 | |||||
| 9-Day RSI | 43.84 | |||||
| 14-Day RSI | 47.71 | |||||
| 6-1 Month Momentum % | -9.84 | |||||
| 12-1 Month Momentum % | -8.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.71 | |||||
| Quick Ratio | 2.52 | |||||
| Cash Ratio | 1.41 | |||||
| Days Inventory | 49.13 | |||||
| Days Sales Outstanding | 38.22 | |||||
| Days Payable | 93.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 8.77 | |||||
| Dividend Payout Ratio | 1.03 | |||||
| 3-Year Dividend Growth Rate | -30.6 | |||||
| Forward Dividend Yield % | 8.77 | |||||
| 5-Year Yield-on-Cost % | 7.69 | |||||
| 3-Year Average Share Buyback Ratio | 0.2 | |||||
| Shareholder Yield % | 8.3 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.14 | |||||
| Operating Margin % | 11.73 | |||||
| Net Margin % | 11.24 | |||||
| FCF Margin % | 3.48 | |||||
| ROE % | 9.76 | |||||
| ROA % | 5.73 | |||||
| ROIC % | 9.76 | |||||
| ROC (Joel Greenblatt) % | 20.98 | |||||
| ROCE % | 8.18 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.91 | |||||
| Forward PE Ratio | 9.3 | |||||
| PE Ratio without NRI | 15.51 | |||||
| Shiller PE Ratio | 11.43 | |||||
| Price-to-Owner-Earnings | 40.95 | |||||
| PS Ratio | 1.65 | |||||
| PB Ratio | 1.39 | |||||
| Price-to-Tangible-Book | 1.47 | |||||
| Price-to-Free-Cash-Flow | 35.32 | |||||
| Price-to-Operating-Cash-Flow | 14.31 | |||||
| EV-to-EBIT | 11.78 | |||||
| EV-to-EBITDA | 11.78 | |||||
| EV-to-Revenue | 1.53 | |||||
| EV-to-FCF | 44.15 | |||||
| Price-to-Projected-FCF | 1.08 | |||||
| Price-to-Graham-Number | 1.01 | |||||
| Price-to-Net-Current-Asset-Value | 5.59 | |||||
| Earnings Yield (Greenblatt) % | 8.49 | |||||
| FCF Yield % | 2.24 | |||||
| Forward Rate of Return (Yacktman) % | -0.99 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Rongtai Health Technology Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 1,721.272 | ||
| EPS (TTM) (Â¥) | 1.012 | ||
| Beta | 1.24 | ||
| Volatility % | 39.92 | ||
| 14-Day RSI | 47.71 | ||
| 14-Day ATR (Â¥) | 0.616106 | ||
| 20-Day SMA (Â¥) | 15.28 | ||
| 12-1 Month Momentum % | -8.78 | ||
| 52-Week Range (Â¥) | 11.12 - 19.430769 | ||
| Shares Outstanding (Mil) | 177.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Rongtai Health Technology Corp Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Rongtai Health Technology Corp Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shanghai Rongtai Health Technology Corp Ltd Frequently Asked Questions
What is Shanghai Rongtai Health Technology Corp Ltd(SHSE:603579)'s stock price today?
The current price of SHSE:603579 is ¥15.09. The 52 week high of SHSE:603579 is ¥19.43 and 52 week low is ¥11.12.
When is next earnings date of Shanghai Rongtai Health Technology Corp Ltd(SHSE:603579)?
The next earnings date of Shanghai Rongtai Health Technology Corp Ltd(SHSE:603579) is .
Does Shanghai Rongtai Health Technology Corp Ltd(SHSE:603579) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Rongtai Health Technology Corp Ltd(SHSE:603579) is 8.77% (As of Today), Highest Dividend Payout Ratio of Shanghai Rongtai Health Technology Corp Ltd(SHSE:603579) was 1.33. The lowest was 0.17. And the median was 0.44. The  Forward Dividend Yield % of Shanghai Rongtai Health Technology Corp Ltd(SHSE:603579) is 8.77%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers